Add us as a preferred source
The latest innovations in healthcare, including a new London cancer centre, digital pharmacy rollouts, regional imaging platforms, social care software acquisitions, preventative weight management, private oncology partnerships, ophthalmic referral pathways, gastrointestinal diagnostic expansions, and clinical expert communities.
SIGN UP TO OUR INNOVATIONS IN HEALTHCARE LINKEDIN NEWSLETTER.
The Clementine Churchill Hospital develops London Cancer Centre
The Clementine Churchill Hospital is to develop a new cancer centre at its 98-bed private hospital facility in Harrow.
The project marks a significant multi-year investment by parent company Circle Health Group to expand advanced oncology diagnosis, treatment and patient support services across North-West London. Construction on the dedicated hub officially began in May, with phase one of the development scheduled for completion in September.
The expansion addresses a pressing clinical need for specialist oncology infrastructure outside central London. To streamline regional access, the new centre will establish end-to-end care pathway under one roof, integrating inpatient and outpatient facilities. The clinical suite will feature dedicated oncology pharmacy services, rapid assessment clinics, advanced diagnostic imaging and access to next-generation robotic-assisted surgical systems – including the da Vinci 5 platform. Patients will also have direct access to systemic anti-cancer therapies (SACT) including chemotherapy, immunotherapy, and targeted molecular treatments.
Operationally, the hub will work in close coordination with its sister facility, Bishops Wood Hospital in Northwood, to create a shared network of oncology expertise, staffing and clinical collaboration across North-West London. The site will also incorporate an expanded and refreshed Intensive Care Unit to provide enhanced acute clinical support for complex patient pathways.
“Our ambition is to create a centre of excellence where advanced technology meets compassionate, personalised care,” said Lisa Trybus, executive director of The Clementine Churchill Hospital.
CareFlow Pharmacy to roll out across Ireland’s hospitals
The Health Service Executive (HSE) and healthtech provider System C will deploy the CareFlow Pharmacy platform in every public hospital across the Republic of Ireland.
The rapid deployment programme represents a major structural modernisation of the HSE’s pharmacy infrastructure, replacing fragmented, paper-based prescription processes with a unified digital ecosystem. The initiative aims to enhance medication safety, streamline inventory control, and bring unprecedented transparency and cost control to billions of euros worth of drug prescriptions across the state.
The nationwide rollout has progressed rapidly, with nine hospitals already live following an intensive initial deployment schedule. The system started at The Rotunda Hospital and successfully expanded through clinical sites including St. Vincent’s University Hospital, Children’s Health Ireland at Crumlin, and Tallaght University Hospital.
The next phase of the national agreement is currently underway, with a further 12 hospital sites scheduled to go live by the end of the year. A subsequent third phase, scheduled to begin later this year, will extend the platform to the remaining 34 hospitals, ultimately bringing more than 50 nationwide hospital sites into a single connected network.
Once the multi-phase deployment is complete, the initiative will make Ireland one of the first countries in the world to operate a fully integrated digital pharmacy system across its entire public hospital network.
“We’re not just implementing technology, we’re co-creating a digital ecosystem that supports clinicians, empowers patients, and strengthens the health service for the future,” said Guy Lucchi, managing director of healthcare at System C.
West Midlands Imaging Network launches digital imaging platform procurement
Fifteen NHS trusts across the West Midlands have officially started a procurement process to launch the Converged Digital Imaging Platform, marking the largest digital health initiative of its kind in Europe.
The tech initiative is designed to transform scan access for more than 6.6 million people by creating a single, interoperable diagnostic imaging record for every NHS patient across the region. By consolidating fragmented data from multiple legacy networks, the programme aims to level-up care delivery, remove geographical barriers and ensure high-quality, precision diagnoses for suspected cancers, heart conditions and traumatic injuries, regardless of where a patient lives.
The deployment is one of the most complex digital undertakings ever attempted within the health service, requiring the alignment of multiple radiology information systems (RIS) and picture archiving and communication systems (PACS).
Once implemented, the platform will empower frontline medical staff – including A&E departments, stroke specialists and operating theatres – by placing a complete, longitudinal imaging history directly at their fingertips to inform time-critical clinical decisions. Furthermore, the infrastructure will enable true cross-site reporting, allowing regional imaging teams to view and report on scans taken at any site, thereby optimising capacity planning and safely accelerating the adoption of advanced innovations like artificial intelligence and machine learning at scale.
The phased rollout is scheduled to take effect as individual agreements with existing technology suppliers gradually expire, a strategy expected to save participating trusts significant amounts of money compared to individually managed contracts. Beyond administrative and fiscal efficiency, the system will break down long-standing barriers for patients over time, promoting greater choice regarding when and where they undergo their scans. Simon Constable, chair of the West Midlands Imaging Network and chief executive at University Hospitals of North Midlands NHS Trust, described the move as a “once in a generation” opportunity to harness diagnostic expertise on an unprecedented scale.
Person Centred Software acquires Camascope
Guildford-based social care software provider Person Centred Software (PCS) has acquired London-based software developer Camascope.
The transaction is designed to bring together medication management and digital care solutions, connecting medication data directly to the UK’s largest structured social care dataset. By joining a person’s electronic medication administration record to wider clinical notes – such as hydration, falls, and daily activities – the initiative should help care providers deliver safer, smarter and more connected care without requiring frontline teams to piece disparate administrative systems together.
The integration addresses a risk vector within UK social care workflows, where paper-based processes and siloed data have historically driven operational friction. The Care Quality Commission (CQC) estimates that roughly 237 million medication errors occur in England every year across health and adult social care settings, with missed doses and incorrect administration putting vulnerable individuals at risk while placing intense pressure on overstretched care teams. By shifting from a simple record of administration toward proactive medication intelligence, the connected platform plans to use data from the care record to provide care teams with actionable insights, benchmarking, and clear evidence of care quality.
Following the acquisition, former Camascope chief executive Kehan Zhou has been appointed group chief executive of the combined PCS Group, which also includes children’s care software specialists Clearcare.
CheqUp partners with Bluecrest Wellness
UK weight management platform CheqUp and health assessment provider Bluecrest Wellness have partnered to integrate clinical weight treatment with preventative health insights.
The collaboration establishes a connected “Weight Health” ecosystem designed to deliver continuous, behaviourally anchored care that treats weight regulation as a long-term medical outcome rather than an isolated metric.
The initiative comes amid escalating domestic demand for preventative care, with Bluecrest currently completing approximately 160,000 diagnostic assessments annually across 400 locations nationwide, while nearly two-thirds (64%) of adults in England are currently classified as overweight or living with obesity.
Under the terms of the new model, CheqUp members will be systematically referred to Bluecrest at the beginning of their treatment to establish baseline biological metrics. This allows clinical teams to track objective physiological shifts – including variations in key blood markers and body composition – as patients advance through the programme. Conversely, Bluecrest customers identified as being at elevated risk for weight-related chronic illnesses will gain a direct referral pathway into CheqUp’s treatment frameworks.
By connecting early health intelligence with structured clinical oversight, the two organisations aim to transition the broader market approach to weight management from a reactive framework to a preventative one. CheqUp, which currently supports more than 60,000 members across the UK, will provide the underlying clinical review and individual approval for all directed therapies.
“For many people, weight is just the starting point, and it is often connected to wider health risks. It is vital that people have a clearer picture of their health as they decide what to do next and this partnership ensures this essential process is all happening in one place,” said Lisa Tookey, chief executive officer of CheqUp.
GenesisCare to deliver private cancer services in Dorset
Independent oncology provider GenesisCare has been selected by University Hospitals Dorset (UHD) NHS Foundation Trust as its preferred partner to deliver private cancer services across the region.
The 20-year agreement is expected to deliver more than £50 million of long-term investment into local NHS cancer care, ensuring both NHS and private patients across the South West can access advanced oncological treatments. Under the terms of the agreement, the capital injection will support the recruitment of additional consultant capacity and generate sustainable income to be directly reinvested into the trust’s core NHS services.
As part of the strategic partnership, GenesisCare will develop a dedicated private patient facility at Poole Hospital. The new unit will deliver a comprehensive range of radiotherapy and Systemic Anti-Cancer Therapy (SACT) services, including complex chemotherapy and immunotherapy regimens. This clinical infrastructure investment, combined with UHD’s existing funding, is designed to expand regional treatment capacity and reduce waiting times, enabling oncology patients to start their therapeutic pathways much sooner.
Design finalisation for the purpose-built medical facility is currently underway, with the site expected to open to patients from autumn 2027.
“By combining local clinical excellence with the benefit of GenesisCare’s national network of expertise we will create something very special that will deliver tangible benefits to both the NHS and to patients wanting to access private cancer care,” said Paul Gearing, chief growth officer of GenesisCare.
Optegra connects with community optometrists
Optegra Eye Health Care plans to strengthen collaboration with community optometrists who are referring patients to the hospital group for private treatment. The new programme – formally known as ConnectedCare – aims to create a referral and follow-up pathway between Optegra clinics and optometry practices around the country.
The strategic focus centres on returning vision correction and private cataract patients to their original community optometrists for ongoing care.
Participating optometrists will be able to refer private patients to Optegra for advanced cataract and vision correction procedures while maintaining continuity of clinical care. Following the primary treatment and initial post-operative medical checks at Optegra, patients are directed back to their local practices. Optometrists then conduct a dedicated wellbeing check-in call to follow up with the patient, encourage them to safely maintain their aftercare regime, and complete a digital assessment on Optegra’s portal.
The initiative has been designed as an administrative-light process for community practices, providing an opportunity for optometrists to increase their own revenue. The optometry practice is financially compensated for delivering the welfare call and completing the online assessment, helping to maintain strong, ongoing patient relationships.
Expansion for The Functional Gut Clinic in Manchester
The Functional Gut Clinic, a specialist provider of digestive health diagnostics, has expanded its Manchester operations into a new facility. The corporate relocation positions the clinic at CityLabs, a flagship biomedical campus situated at the heart of Manchester’s innovation district.
The newly developed facility has been designed to scale the provider’s operational and research capabilities across several core clinical areas. The infrastructure will house an expanded diagnostics centre offering the clinic’s full suite of specialist gut and digestion tests, alongside a dedicated clinical trials facility integrated within the wider CityLabs research ecosystem to accelerate UK digestive health research. Furthermore, the site establishes a dedicated gut health offering to support the “democratisation of digestion,” aiming to make comprehensive gut wellness diagnostics accessible to a broader demographic of patients.
Financially backed by a £5.75 million investment from Foresight Group last year, the expansion heavily focuses on strengthening collaborative ties with public healthcare providers.
The increased capacity is structured to support the NHS by delivering specialist tertiary-care diagnostics in close partnership with regional NHS hospitals.
Claire Alvarez, partner at Foresight Group, noted that the location gives the organisation the necessary space, technology and infrastructure to scale services nationally, while founder Anthony Hobson emphasised that the city remains the definitive anchor for the clinic’s future innovation in gastrointestinal physiology.
Health Tech Enterprise launches Clinical Expert Community
Health Tech Enterprise (HTE) has launched the Clinical Expert Community, a new initiative designed to address one of the primary hurdles encountered by medical technology developers: securing meaningful clinical insight during product creation.
The programme establishes a bridge between frontline medical staff – including doctors, nurses and allied health professionals – and companies designing medical devices, diagnostics and digital health software. By integrating real-world medical expertise into the early design phases, the platform wants to develop practical tools that improve clinical outcomes across the health service.
The specialised consultancy developed the community framework in response to a widespread industry mismatch, where promising technologies frequently fail to achieve market adoption because they do not align with complex clinical workflows. Too often, significant investments are made in medical hardware or digital platforms that inadvertently disrupt patient pathways or overlook the practical constraints of frontline care delivery.
Through this network, healthcare professionals can evaluate emerging technologies and provide targeted feedback regarding usability, clinical workflow compatibility and potential patient impact well before the systems reach the commercial market.
Members joining the community will secure early visibility into emerging medical technologies directly relevant to their specific clinical fields. Engagement is structured to be highly flexible, allowing busy healthcare workers to participate via short surveys, virtual focus groups, individual interviews, or practical, hands-on usability testing as their schedules permit.
“Healthcare professionals understand the challenges facing patient care better than anyone, yet innovators can often struggle to access that insight during product development. Our clinical expert community connects healthcare professionals with medtech innovators, helping to ensure new technologies are designed around real-world clinical needs, improve patient outcomes and are more likely to be successfully adopted in practice,” said Anne Blackwood, chief executive for Health Tech Enterprise.
